Unknown

Dataset Information

0

Size-controlled insulin-secreting cell clusters.


ABSTRACT: The search for an effective cure for type I diabetes from the transplantation of encapsulated pancreatic ?-cell clusters has so far produced sub-optimal clinical outcomes. Previous efforts have not controlled the size of transplanted clusters, a parameter implicated in affecting long-term viability and the secretion of therapeutically sufficient insulin. Here we demonstrate a method based on covalent attachment of patterned laminin for fabricating uniformly size-controlled insulin-secreting cell clusters. We show that cluster size within the range 40-120?m in diameter affects a variety of therapeutically relevant cellular responses including insulin expression, content and secretion. Our studies elucidate two size-dependent phenomena: (1) as the cluster size increases from 40?m to 60?m, glucose stimulation results in a greater amount of insulin produced per cell; and (2) as the cluster size increases beyond 60?m, sustained glucose stimulation results in a greater amount of insulin secreted per cell. Our study describes a method for producing uniformly sized insulin-secreting cell clusters, and since larger cluster sizes risk nutrient availability limitations, our data suggest that 100-120?m clusters may provide optimal viability and efficacy for encapsulated ?-cell transplants as a treatment for type I diabetes and that further in vivo evaluation is warranted.

SUBMITTER: Mendelsohn AD 

PROVIDER: S-EPMC4030672 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Size-controlled insulin-secreting cell clusters.

Mendelsohn Adam D AD   Nyitray Crystal C   Sena Mark M   Desai Tejal A TA  

Acta biomaterialia 20120814 12


The search for an effective cure for type I diabetes from the transplantation of encapsulated pancreatic β-cell clusters has so far produced sub-optimal clinical outcomes. Previous efforts have not controlled the size of transplanted clusters, a parameter implicated in affecting long-term viability and the secretion of therapeutically sufficient insulin. Here we demonstrate a method based on covalent attachment of patterned laminin for fabricating uniformly size-controlled insulin-secreting cell  ...[more]

Similar Datasets

| S-EPMC10261893 | biostudies-literature
| S-EPMC5333835 | biostudies-literature
| PRJNA382426 | ENA
| PRJNA382425 | ENA
| S-EPMC1147757 | biostudies-other
| S-EPMC3508785 | biostudies-literature
| S-EPMC5446400 | biostudies-other
| S-EPMC4025576 | biostudies-literature
| S-EPMC5668012 | biostudies-literature
2019-02-25 | PXD011329 | Pride